|
[1]王宝恩, 张定凤.现代肝脏病学[M].北京:科学出版社, 2003, 8:851.
|
|
[2]郭卫平, 刘燕, 王执民, 等.兔肝VX2移植癌改良模型的建立[J].中国医学影像技术, 2002, 18 (5) :397-399.
|
|
[3]曹玮, 王执民, 张洪新, 等.兔VX2肝癌模型的移植方式及生长特性的研究[J].实用放射学杂志, 2003, 19 (2) :97-99.
|
|
[4]Lin WY, Chen J, Lin Y, et al.Implantation of VX2 carcinoma into theliver of rabbits:a comparison of three direct-injection methods[J].JVet Med Sci, 2002, 64 (7) :649-652.
|
|
[5]Izumi B, Tashiro S, Miyauchi Y, et al.Anticancer effects of localadministration of mitomycin C via the hepatic artery or portal veinon implantion and growth of VX2 cancer injected into rabbit liver[J].Cancer Res, 1986, 46 (8) :4167-4170.
|
|
[6]Paeng JC, Jeong JM, Yoon CJ, et al.Lipiodol solution of 188ReHDDas a new therapeutic agent for transhepatic arterial embolizationin liver cancer:preclinical study in a rabbit liver cancer model[J].Nucl Med, 2003, 44 (12) :2033-2038.
|
|
[7]Yoon CJ, Chung JW, Park JH, et al.Transcatheter arterialchemoembolization with paclitaxel-lipiodol solution in rabbit VX2liver tumour[J].Radiology, 2003, 229 (1) :126-131.
|
|
[8]Hansler J, Neureiter D, Wasserburger M, et al.Percutaneous US-guided radiofrequency ablation with perfused needle applicators:improved survival with the VX2 tumor model in rabbits[J].Radiology, 2004, 230 (1) :169-174.
|
|
[9]Lindell B, AronSen KF, Rothman U, et al.Repated arterialembolization of rat livers by de-grdable microspheres[J].Eur SurgRes, 1988, 9 (5) :347-35.
|
|
[10]红雷, 张玉, 栗林.兔摄食行为的观察与分析[J].畜牧与饲料科学, 2005, 26 (6) :47-48.
|
|
[11]Nagata Y, Fujiwara K, Okajima K, et al.Transcatheter arterialembolization for malignant osseous and soft tissue sarcomas.Ⅰ.Arabbit experimental model[J].Cardiovase Intervent Radiol, 1998, 21 (3) :205-207.
|
|
[12]Ko YH, Pedersen PL, Geschwind JF.Glucose catabolism in therabbit VX2 tumor model for liver cancer:characterization andtargeting hexokinase[J].Cancer Lett, 2001, 173 (1) :83-91.
|
|
[13]Moroz P, Jones SK, Winter J, et al.Targeting liver tumors withhyperthermia:ferromagnetic embolization in a rabbitliver tumormodel[J].J Surg Oncol, 2001, 78 (1) :22-29.
|
|
[14]王学梅, 周旭.肝癌超声诊断与治疗现状综合论坛[J].超声医学论坛, 2002, 8 (1) :6466.
|
|
[15]Ogata R, Majima Y, Tateishi Y, et al.Bright loop apperance;a characteristic ultrasonography sign of early hepatocellularcarcinoma[J].Oncol Rep, 2000, 7 (6) :1293-1298.
|
|
[16]李杰, 梁萍.彩色多着超声和超声造影在肝脏占住性病变中的应用进展[J].消化外科, 2002, 1 (5) :377-380.
|
|
[17]Deng CX, Lizzi FL.A review of physical phenomena associated withultrasonic contrast agents and illustrative clinical applications[J].Ultrasound Med Biol, 2002, 28 (3) :277-286.
|
|
[18]Voigt JU.Ultrasound molecular imaging[J].Methods, 2009, 48:92-97.
|
|
[19]Pike R, Sabatier P.Scattering:scattering and inverse scattering inpure and applied science[M].London:Academic Press, 2002:162-174.
|
|
[20]Guan J, Matula TJ.Using light scattering to measure the responseof individual ultrasound contrast microbubbles subjected to pulsedultrasound in vitro[J].J Acoust Soc Am, 2004, 116 (5) :2832-2842.
|
|
[21]Mattrey RF, Aguirre DA.Advances in contrast media research[J].Acdemic Radiology, 2003, 10 (12) :1450-1460.
|
|
[22]Oeffinger BE, Wheatley MA.Development and characterization of anano-scale contrast agent[J].Ultrasonics, 2004, 42 (5) :343-347.
|
PDF下载 ( 2712 KB)
本文二维码
下载:
